Skip to content

H.R. 1864 · 119th Congress (2025–2027)

Risky Research Review Act

This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research. High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola).

Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review.

In making its determinations, the board must consider specified factors, including whether the benefits of the research outweigh the risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also review awards that were made before the bill’s enactment.

Entities that fail to properly attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.

Show official title

To amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1864’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. H. Morgan Griffith (R-VA-9)
Policy area
Health
Subjects
  • Accounting and auditing
  • Advisory bodies
  • Biological and life sciences
  • Congressional oversight
  • Employee performance
  • Federal officials
  • Government employee pay, benefits, personnel management
  • Government ethics and transparency, public corruption
  • 5 more
    • Government information and archives
    • Government studies and investigations
    • Infectious and parasitic diseases
    • Public contracts and procurement
    • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 5, 2025
  2. HouseScience, Space, and TechnologyReferred Mar 5, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Risky Research Review Act

    Display title, Short title · Introduced in House

  2. To amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes.

    Official title · Introduced in House